A randomized controlled trial of haemoglobin normalization with epoetin alfa in pre-dialysis and dialysis patients.

No abstract is available for this paper.

• Publication year

  2003

• Venue

  Nephrology, Dialysis and Transplantation

• Publication date

  2003-02-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1093/NDT/18.2.353PMID 12543892
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Revised European best practice guidelines for the management of anaemia in patients with chronic renal failure.

  2004cited by this paper
• Normalization of haemoglobin concentration with recombinant erythropoietin has minimal effect on blood haemostasis.

  2001cited by this paper
• THE USE OF PRETRANSPLANT ERYTHROPOIETIN TO NORMALIZE HEMOGLOBIN LEVELS HAS NO DELETERIOUS EFFECTS ON RENAL TRANSPLANTATION OUTCOME1

  2001cited by this paper
• THE EFFECTS OF NORMAL AS COMPARED WITH LOW HEMATOCRIT VALUES IN PATIENTS WITH CARDIAC DISEASE WHO ARE RECEIVING HEMODIALYSIS AND EPOETIN

  2000influential reference
• Increasing the hematocrit has a beneficial effect on quality of life and is safe in selected hemodialysis patients. Spanish Cooperative Renal Patients Quality of Life Study Group of the Spanish Society of Nephrology.

  2000cited by this paper
• Effect of hemoglobin levels in hemodialysis patients with asymptomatic cardiomyopathy.

  2000cited by this paper
• Erythropoietin and arterial hypertension.

  2000cited by this paper
• Effects of haemoglobin normalization on quality of life and cardiovascular parameters in end-stage renal failure.

  2000cited by this paper
• Cardiovascular effect of normalizing the hematocrit level during erythropoietin therapy in predialysis patients with chronic renal failure.

  2000cited by this paper
• Physical performance and associated electrolyte changes after haemoglobin normalization: a comparative study in haemodialysis patients.

  1999cited by this paper
• Normalizing hematocrit in dialysis patients improves brain function.

  1999cited by this paper
• Review of issues relating to iron and infection.

  1999cited by this paper
• European best practice guidelines for the management of anaemia in patients with chronic renal failure.

  1999cited by this paper
• Mechanism of erythropoietin-induced hypertension.

  1999cited by this paper
• The effects of normal as compared with low hematocrit values in patients with cardiac disease who are receiving hemodialysis and epoetin.

  1998cited by this paper
• Reversal of anemia by erythropoietin therapy retards the progression of chronic renal failure, especially in nondiabetic patients.

  1997cited by this paper
• Outcome and risk factors for left ventricular disorders in chronic uraemia.

  1996cited by this paper
• The effects of recombinant human erythropoietin on functional health and well-being in chronic dialysis patients.

  1996cited by this paper
• A disease-specific questionnaire for assessing quality of life in patients on hemodialysis.

  1992cited by this paper
• Regression of left ventricular hypertrophy after partial correction of anemia with erythropoietin in patients on hemodialysis: a prospective study.

  1991cited by this paper
• Exercise in hemodialysis patients after treatment with recombinant human erythropoietin.

  1991cited by this paper

• Reporting of patient-reported outcomes (PROs) in randomized controlled trials of anemia treatments for people with CKD: a scoping review.

  2026cites this paper
• Efficacy of the bicarbonate dialysate with acetate concentrations of 0–0.3 and 3–5: A systematic review and meta‐analysis

  2025cites this paper
• IN THIS ISSUE

  2023cites this paper
• Interventions for fatigue in people with kidney failure requiring dialysis.

  2023cites this paper
• Poor recognition and undertreatment of anemia in patients with chronic kidney disease managed in primary care

  2023cites this paper
• Erythropoiesis-stimulating agents for anaemia in adults with chronic kidney disease: a network meta-analysis.

  2023cites this paper
• Comparison of darbepoetin alpha and recombinant human erythropoietin for treatment of anemia in pediatric chronic kidney disease: a non-inferiority trial from India

  2022cites this paper
• Anemia Prevalence, Type, and Associated Risks in a Cohort of 5.0 Million Insured Patients in the United States by Level of Kidney Function.

  2022cites this paper
• Efficacy and safety of recombinant human erythropoietin (Hema-Plus®) for management of anemia in Thai patients on peritoneal dialysis

  2021cites this paper
• Physical health-related quality of life at higher achieved hemoglobin levels among chronic kidney disease patients: a systematic review and meta-analysis

  2020cites this paper
• Revisiting the treatment of anemia in the setting of chronic kidney disease, hematologic malignancies, and cancer: perspectives with opinion and commentary

  2020cites this paper
• Survival Percentile and Predictors of Difference in Survival among Hemodialysis Patients and Their Additive Interaction Using Laplace Regression

  2020cites this paper
• Predictors of mortality among hemodialysis patients in Hamadan province using random survival forests

  2020cites this paper
• A rule extraction approach to explore the upper limit of hemoglobin during anemia treatment in patients with predialysis chronic kidney disease

  2019cites this paper
• Patient-Centred Outcomes in Anaemia and Renal Disease: A Systematic Review

  2019influential citation
• The Evolution of Target Hemoglobin Levels in Anemia of Chronic Kidney Disease.

  2019cites this paper
• Economic and quality of life burden of anemia on patients with CKD on dialysis: a systematic review

  2019influential citation
• Lessons from clinical trials with erythropoiesis-stimulating agents (ESAs)

  2018cites this paper
• Patient Blood Management: An Internist's Perspective

  2018cites this paper
• Hemoglobin targets for the anemia in patients with dialysis-dependent chronic kidney disease: a meta-analysis of randomized, controlled trials

  2018cites this paper
• Collection and determinants of patient reported outcome measures in haemodialysis patients in Scotland

  2018cites this paper
• The Relationship Between Fatigue and Depression in Adults With End-Stage Renal Disease on Chronic In-Hospital Hemodialysis: A Scoping Review.

  2017influential citation
• Predictors of long-term survival of hemodialysis patients in Hamadan province, west of Iran

  2017cites this paper
• De novo weekly and biweekly darbepoetin alfa dosing in pediatric patients with chronic kidney disease

  2017cites this paper
• The influence of different dialysis modalities on the quality of life of patients with end-stage renal disease: A systematic literature review

  2016cites this paper
• Comparison between Erythropoietin Alfa Biosimilars and Reference Product in Anemic Patients of Chronic Kidney Disease

  2016cites this paper
• CYTOMEGALOVIRUS INFECTION; PREVALENCE IN HEMODIALYSIS PATIENTS IN DIALYSIS UNIT OF LAHORE GENERAL HOSPITAL

  2016cites this paper
• Association between Raised Serum C-Reactive Protein and Arteriovenous Fistula Failure

  2016influential citation
• The Effect of Erythropoietin-Stimulating Agents on Health-Related Quality of Life in Anemia of Chronic Kidney Disease

  2016cites this paper
• Correlation between CRP and early failure of arteriovenous fistula (AVF)

  2015cites this paper
• Early versus delayed erythropoietin for the anaemia of end-stage kidney disease.

  2015cites this paper
• Association Between Vascular Access Dysfunction and Subsequent Major Adverse Cardiovascular Events in Patients on Hemodialysis

  2015cites this paper
• A cross-sectional, correlational survey to explore the relationship between Renal Association biochemical and haematological markers and health-related quality of life in patients receiving haemodialysis in the North West of England.

  2015cites this paper
• Comparison of the Therapeutic Effects of Two Recombinant Erythropoietin Beta, Biosimilar and Reference Formulations in Patients with Chronic Kidney Disease under Hemodialysis

  2014cites this paper
• Responsiveness to Erythropoiesis-Stimulating Agents in Chronic Kidney Disease: Does Geography Matter?

  2014cites this paper
• Association of higher erythropoiesis stimulating agent dose and mortality in children on dialysis

  2014cites this paper
• Mortality and Cardiovascular Morbidity Associated with Haemoglobin Levels: A Pooled Analysis of Randomised Controlled Trials

  2014cites this paper
• Biomedical system dynamics to improve anemia control with darbepoetin alfa in long-term hemodialysis patients.

  2014cites this paper
• optImaL target hemogLoBIn LeveL In patIents WIth ChronIC kIDney DIsease anD anemIa treateD WIth erythropoIesIs-stImuLatIng agents : ControversIaL Issues

  2014cites this paper
• Erythropoiesis-stimulating agents for anaemia in adults with chronic kidney disease: a network meta-analysis.

  2014cites this paper
• Anemia and Disorders of Hemostasis in Chronic Kidney Disease

  2014cites this paper
• Erythropoiesis-Stimulating Agents (ESA) for Preventing the Progression of Chronic Kidney Disease: A Meta-Analysis of 19 Studies

  2014cites this paper
• Erythropoiesis-Stimulating Agents (ESA) for Preventing the Progression of Chronic Kidney Disease: A Meta-Analysis of 19 Studies

  2014cites this paper
• Anaemia Management in Chronic Kidney Disease

  2014cites this paper
• Dose of erythropoiesis-stimulating agents and adverse outcomes in CKD: a metaregression analysis.

  2013cites this paper
• The impact of hyporesponsiveness to erythropoietin-stimulating agents on time-dependent mortality risk among CKD stage 5D patients: a single-center cohort study

  2013influential citation
• Influence of safety warnings on ESA prescribing among dialysis patients using an interrupted time series

  2013cites this paper
• Renal Anemia Control in Lithuania: Influence of Local Conditions and Local Guidelines

  2013cites this paper
• Data Mining Performance in Identifying the Risk Factors of Early Arteriovenous Fistula Failure in Hemodialysis Patients

  2013cites this paper
• Rapid detection of erythropoiesis-stimulating agents in urine and serum.

  2012cites this paper
• Safety issues related to erythropoiesis-stimulating agents used to treat anemia in patients with chronic kidney disease

  2012cites this paper
• Chapter 3: Use of ESAs and other agents* to treat anemia in CKD

  2012cites this paper
• Systematic review of the impact of erythropoiesis-stimulating agents on fatigue in dialysis patients.

  2012influential citation
• Anaemia, diabetes and chronic kidney disease: where are we now?

  2012cites this paper
• Anemia management: one protocol does not fit all.

  2012cites this paper
• Anemia and chronic kidney disease: making sense of the recent trials.

  2012cites this paper
• Hyporesponsiveness to erythropoiesis-stimulating agents and renal survival in non-dialysis CKD patients.

  2012cites this paper
• МЕЖКЛЕТОЧНЫЕ ВЗАИМОДЕЙСТВИЯ В КРОВИ В ПАТОГЕНЕЗЕ НАРУШЕНИЙ ГЕМОСТАЗА У БОЛЬНЫХ ХРОНИЧЕСКОЙ ПОЧЕЧНОЙ НЕДОСТАТОЧНОСТЬЮ, НАХОДЯЩИХСЯ НА ГЕМОДИАЛИЗЕ

  2012cites this paper
• Hemoglobin Targets for Chronic Kidney Disease Patients with Anemia: A Systematic Review and Meta-analysis

  2012cites this paper
• Hematologic Aspects of Kidney Disease

  2012cites this paper
• Biomarkers for Assessing and Managing Iron Deficiency Anemia in Late-Stage Chronic Kidney Disease

  2012cites this paper
• Iron Inhibits Respiratory Burst of Peritoneal Phagocytes In Vitro

  2011cites this paper
• Positive Outcomes of High Hemoglobin Target in Patients With Chronic Kidney Disease Not on Dialysis: A Randomized Controlled Study

  2011cites this paper
• Critical appraisal of randomized controlled trials of anemia correction in patients with renal failure

  2011cites this paper
• Renal Association Clinical Practice Guideline on Anaemia of Chronic Kidney Disease

  2011cites this paper
• Subjective Well-Being Measures of Hemodialysis Patients

  2011cites this paper
• KDIGO clinical practice guidelines for bisphosphonate treatment in chronic kidney disease.

  2011cites this paper
• Naturally occurring higher hemoglobin concentration does not increase mortality among hemodialysis patients.

  2011cites this paper
• Anemia and Progression of Chronic Kidney Disease

  2011cites this paper
• Impact of pain and symptom burden on the health-related quality of life of hemodialysis patients.

  2010cites this paper
• Cardiorenal syndrome and heart failure

  2010cites this paper
• Treating anemia in heart failure patients: a review of erythropoiesis-stimulating agents

  2010cites this paper
• An economic evaluation of erythropoiesis-stimulating agents in CKD.

  2010cites this paper
• Sex-specific association of time-varying haemoglobin values with mortality in incident dialysis patients.

  2010cites this paper
• Meta-analysis: Erythropoiesis-Stimulating Agents in Patients With Chronic Kidney Disease

  2010influential citation
• Summary and Comment: Erythropoietin Bundling: Innovative Remuneration or the Dawn of EPO‐Profiling?

  2010cites this paper
• Increase in post‐dialysis hemoglobin can be out of proportion and unrelated to ultrafiltration

  2010cites this paper
• Individualizing anaemia therapy

  2010cites this paper
• Systematic review and meta-analysis of exercise tolerance and physical functioning in dialysis patients treated with erythropoiesis-stimulating agents.

  2010cites this paper
• Depression and health-related quality of life in maintenance hemodialysis patients.

  2010cites this paper
• Cardiovascular Effects of Growth Hormone in Adult Hemodialysis Patients: Results from a Randomized Controlled Trial

  2010cites this paper
• The impact of fatigue on daily activity in people with chronic kidney disease.

  2010cites this paper
• Individualizing anaemia therapy

  2010cites this paper
• Studies of Depression and Illness Representations in End-Stage Renal Disease

  2010cites this paper
• Laboratories variables as indicators of quality of life in elderly under substitution treatment of renal function

  2010cites this paper
• Anemia in renal disease: diagnosis and management.

  2010cites this paper
• Multidisciplinary Care Improves Outcome of Patients with Stage 5 Chronic Kidney Disease

  2010cites this paper
• Metal ion and vitamin adsorption profiles of phosphate binder ion-exchange resins.

  2010cites this paper
• Switching epoetin alfa and epoetin zeta in patients with Renal Anemia on Dialysis: Posthoc analysis

  2010cites this paper
• Healthcare Expenditure and Resource Utilization in Patients with Anaemia and Chronic Kidney Disease: A Retrospective Claims Database Analysis

  2009cites this paper
• Erythropoietin friend or foe in chronic kidney disease anemia: an analysis of randomized controlled trials, observational studies and meta-analyses.

  2009cites this paper
• 2 Quality of life in patients on peritoneal dialysis

  2009cites this paper
• Anaemia as a risk factor for chronic kidney disease

  2009cites this paper
• The impact of selecting a high hemoglobin target level on health-related quality of life for patients with chronic kidney disease: a systematic review and meta-analysis.

  2009cites this paper
• [Anemia in chronic kidney disease and its cardiovascular implications].

  2009cites this paper
• Interpretation and review of health-related quality of life data in CKD patients receiving treatment for anemia.

  2009cites this paper
• What is so bad about a hemoglobin level of 12 to 13 g/dL for chronic kidney disease patients anyway?

  2009cites this paper
• Fatigue in People Undergoing Hemodialysis

  2009cites this paper
• Effect of Epoetin Induced Normal Hb on Progression of Nephropathy in Insulin Treated Diabetic Patients with Renal Anaemia

  2009influential citation
• Determining patient activity levels in chronic kidney disease

  2009cites this paper